These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8956048)

  • 21. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
    Chokshi N; Blumenschein SD; Ahmad Z; Garg A
    J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
    Brunzell JD; Miller NE; Alaupovic P; St Hilaire RJ; Wang CS; Sarson DL; Bloom SR; Lewis B
    J Lipid Res; 1983 Jan; 24(1):12-9. PubMed ID: 6833877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype.
    Nagai T; Tomizawa T; Saito T; Nakano T; Nakajima K; Mori M
    Intern Med; 1996 May; 35(5):388-91. PubMed ID: 8797053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial chylomicronemia syndrome.
    Sugandhan S; Khandpur S; Sharma VK
    Pediatr Dermatol; 2007; 24(3):323-5. PubMed ID: 17542893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
    Babirak SP; Iverius PH; Fujimoto WY; Brunzell JD
    Arteriosclerosis; 1989; 9(3):326-34. PubMed ID: 2719595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations.
    Hooper AJ; Crawford GM; Brisbane JM; Robertson K; Watts GF; van Bockxmeer FM; Burnett JR
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):102-5. PubMed ID: 18275685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial commentary: Dietary management of familial chylomicronemia syndrome.
    Williams L; Wilson DP
    J Clin Lipidol; 2016; 10(3):462-5. PubMed ID: 27206931
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting APOC3 in the familial chylomicronemia syndrome.
    Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL
    N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound heterozygosity for frameshift mutations in the gene for lipoprotein lipase in a patient with early-onset chylomicronemia.
    Foubert L; De Gennes JL; Benlian P; Truffert J; Miao L; Hayden MR
    Hum Mutat; 1998; Suppl 1():S141-4. PubMed ID: 9452069
    [No Abstract]   [Full Text] [Related]  

  • 31. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
    Blackett P; Tryggestad J; Krishnan S; Li S; Xu W; Alaupovic P; Quiroga C; Copeland K
    J Clin Lipidol; 2013; 7(2):132-9. PubMed ID: 23415432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
    J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
    Berger GM
    Am J Clin Pathol; 1987 Sep; 88(3):369-73. PubMed ID: 3630977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial lipoprotein lipase deficiency].
    Yoshida T; Gotoda T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):84-7. PubMed ID: 9645014
    [No Abstract]   [Full Text] [Related]  

  • 36. Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome.
    Berberich AJ; Hegele RA
    Atherosclerosis; 2024 May; 392():117528. PubMed ID: 38594114
    [No Abstract]   [Full Text] [Related]  

  • 37. Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat.
    Black DM; Sprecher DL
    Am J Dis Child; 1993 Jan; 147(1):60-2. PubMed ID: 8418601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma.
    Musliner TA; Herbert PN; Kingston MJ
    Biochim Biophys Acta; 1979 Nov; 575(2):277-88. PubMed ID: 228741
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
    Hölzl B; Iglseder B; Sandhofer A; Malaimare L; Lang J; Paulweber B; Sandhofer F
    Diabetologia; 2002 Mar; 45(3):378-84. PubMed ID: 11914743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia.
    Rabacchi C; Pisciotta L; Cefalù AB; Noto D; Fresa R; Tarugi P; Averna M; Bertolini S; Calandra S
    Atherosclerosis; 2015 Jul; 241(1):79-86. PubMed ID: 25966443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.